ADC Therapeutics beefs up monster $200M round with fresh $76M haul
Days after Roche secured accelerated approval for its antibody-drug conjugate, Lausanne, Switzerland-based ADC Therapeutics has clinched another $76 million to its already hefty
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.